Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Head and Neck Neoplasms 3Breast Neoplasms 3Hot Flashes 2Vomiting 1Urinary Bladder Neoplasms 1Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Prostatic Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain, Postoperative 1Pain 1Oropharyngeal Neoplasms 1Neuralgia 1Neoplasms 1Nausea 1Mucositis 1Lung Neoplasms 1Laryngeal Diseases 1Acute Pain 1Abnormalities, Radiation-Induced 1

Interventions

Dexamethasone 17Palonosetron 13Aprepitant 13Ondansetron 12Calcium Dobesilate 12Granisetron 7dexamethasone acetate 5Doxorubicin 5Cyclophosphamide 4fosaprepitant 3dexamethasone 21-phosphate 3Vincristine 3Olanzapine 3Cisplatin 3Therapeutics 2Sugars 2Radiotherapy 2Mesna 2Lorazepam 2Ifosfamide 2Fluorouracil 2Dronabinol 2Diphenhydramine 2rolapitant 1netupitant 1isatuximab 1ginger extract 1dolasetron 1casopitant 1auricularum 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Nausea × Gabapentin × Clear all
NCT00880191 2016-07-06

Gabapentin in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
430 enrolled 11 charts

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡